Hydrochloric Acid

Hydrochloric Acid

SCHEMBL4475585

C[Zr](C)(C)(C)(=[SiH2])(=[SiH2])(C1C=Cc2ccccc21)C1C=Cc2ccccc21.Cl.Cl

nearest known ligand 0.34

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ABL1ACEACHEACVR1ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3AGTR1ALKAVPR1AAVPR2BCHEBCRCA2CACNA1ACACNA1BCACNA1CCACNA1DCACNA1ECACNA1FCACNA1GCACNA1HCACNA1ICACNA1SCACNA2D1CACNA2D2CACNA2D3CACNA2D4CACNB1CACNB2CACNB3CACNB4CACNG1CACNG2CACNG3CACNG4CACNG5CACNG6CACNG7CACNG8CALCRLCASRCCR5CDK4CDK6CFBCHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNA3CHRNA7CHRNB1CHRNB4CHRNDCHRNECHRNGCOXFA4COXFA4L2CRBNCSF1RCUL4ACYP19A1DDB1DPP4DRD1DRD2DRD3DRD4EDNRAEGFREML4ERBB2ERBB4ESR1ESR2FGFR1FGFR3FLT1FLT3FLT4GAAGABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGHSRGLAGNRHRGPD2GRIN1GRIN2AGRIN2BGRIN2CGRIN2DGRIN3AGRIN3BGSTP1HCN4HCRTR1HCRTR2HDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HRH2HRH3HSD11B1HSP90AA1HSP90AB1HTR1AHTR1BHTR1DHTR1EHTR1FHTR2AHTR2BHTR2CHTR3AHTR3BHTR3CHTR3DHTR3EHTR4HTR5AHTR6HTR7IMPDH1IMPDH2ITGA2BITGB3ITKJAK1JAK2KCNA1KCNA10KCNA2KCNA3KCNA4KCNA5KCNA6KCNA7KCNB1KCNB2KCNC1KCNC2KCNC3KCNC4KCND1KCND2KCND3KCNF1KCNG1KCNG2KCNG3KCNG4KCNH1KCNH2KCNH3KCNH4KCNH5KCNH6KCNH7KCNH8KCNJ2KCNJ3KCNJ5KCNK3KCNK9KCNQ1KCNQ2KCNQ3KCNQ4KCNQ5KCNS1KCNS2KCNS3KCNV1KCNV2KDRKITKLKB1LCKMMAOAMAOBMAPK14METMMP1MMP13MMP7MMP8MT-ND1MT-ND2MT-ND3MT-ND4MT-ND4LMT-ND5MT-ND6NDUFA1NDUFA10NDUFA11NDUFA12NDUFA13NDUFA2NDUFA3NDUFA5NDUFA6NDUFA7NDUFA8NDUFA9NDUFAB1NDUFAF1NDUFAF2NDUFAF3NDUFAF4NDUFB1NDUFB10NDUFB11NDUFB2NDUFB3NDUFB4NDUFB5NDUFB6NDUFB7NDUFB8NDUFB9NDUFC1NDUFC2NDUFS1NDUFS2NDUFS3NDUFS4NDUFS5NDUFS6NDUFS7NDUFS8NDUFV1NDUFV2NDUFV3NR3C1NS5ANTRK1NTRK2NTRK3ODC1OPRD1OPRK1OPRM1P2RY12PAHPARP1PDE3APDE3BPDE4APDE4BPDE4CPDE4DPDE5APDE7APDE7BPDE8APDE8BPDGFRAPDGFRBPIK3CAPIK3CDPNPPOLA1POLA2POLD1POLD2POLD3POLD4POLEPOLE2POLE3PPARGPRIM1PRIM2PRKCAPRKCBPRKCDPRKCEPRKCGPRKCHPRKCIPRKCQPRKCZPRKD1PRKD3PTGS1PTGS2RBX1RENRETROCK1ROCK2RPE65RRM1RRM2RRM2BS1PR1S1PR2S1PR3S1PR4S1PR5SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASCNN1ASCNN1BSCNN1GSIGMAR1SLC18A2SLC6A1SLC6A2SLC6A3SLC6A4SLC9A3SRCTACR1TOP1TOP2ATOP2BTTRTYMPdacAdacBdacCembAfolAftsIgyrAgyrBmrcAmrcBmrdAparCparEpolrplArplBrplCrplDrplErplFrplIrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmE2rpmFrpmGrpmG1rpmG2rpmG3rpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO

The experimentally established mechanism targets of Hydrochloric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR2A known ✓ P28223 2/20 0.34
HTR6 known ✓ P50406 1/20 0.34
SIGMAR1 known ✓ Q99720 6/20 0.32
CHRM2 known ✓ P08172 1/20 0.32
CHRM1 known ✓ P11229 1/20 0.32
DRD2 known ✓ P14416 1/20 0.32
ADRA2B known ✓ P18089 1/20 0.32
ADRA2C known ✓ P18825 1/20 0.32
CHRM3 known ✓ P20309 1/20 0.32
SLC6A2 known ✓ P23975 1/20 0.32
HTR2C known ✓ P28335 1/20 0.32
ADRA1A known ✓ P35348 1/20 0.32
HRH1 known ✓ P35367 1/20 0.32
DRD3 known ✓ P35462 1/20 0.32
OPRK1 known ✓ P41145 1/20 0.32
HTR2B known ✓ P41595 1/20 0.32
CACNA1B known ✓ Q00975 1/20 0.32
SLC6A3 known ✓ Q01959 1/20 0.32
KCNH2 known ✓ Q12809 1/20 0.32
RET known ✓ P07949 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL29767643 0.84 HTR6 (0.30) HTR2AHTR6
Hydrochloric Acid SCHEMBL8463609 0.76
Hydrochloric Acid SCHEMBL4475726 0.73
Hydrochloric Acid SCHEMBL29767615 0.70 HTR6 (0.30) HTR2AHTR6
SCHEMBL9010269 0.70 BRD4 (0.31) HTR2AHTR6BRD4CCL2
Hydrochloric Acid SCHEMBL8163839 0.69 HTR2A (0.34) HTR2AKDM4EHTR6MEN1PMP22
Hydrochloric Acid SCHEMBL271905 0.69 HTR2A (0.34) HTR2AKDM4EHTR6MEN1PMP22
SCHEMBL2930945 0.67 CYP2D6 (0.41) HTR2AKDM4EHTR6MEN1PMP22
SCHEMBL14956869 0.67 CYP2D6 (0.41) HTR2AKDM4EHTR6MEN1PMP22
SCHEMBL639420 0.67 CYP2D6 (0.41) HTR2AKDM4EHTR6MEN1PMP22

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 51 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3322529-A1 SUBSTITUTED BIS INDENYL METALLOCENE CATALYST COMPOUNDS COMPRISING-SI-SI-BRIDGE ExxonMobil Chemical Patents Inc. (US) 2018-05-23 EP disclosed
WO-2017011073-A1 SUBSTITUTED BIS INDENYL METALLOCENE CATALYST COMPOUNDS COMPRISING-SI-SI-BRIDGE EXXONMOBIL CHEMICAL PATENTS INC. (US) 2017-01-19 WO disclosed
EP-1880986-B1 PROCESS FOR PRODUCING SATURATED ALIPHATIC HYDROCARBONS, AND LUBRICANT COMPOSITIONS THEREOF IDEMITSU KOSAN CO (JP) 2013-03-06 EP disclosed
US-8373011-B2 Used in a base oil of lubricant having good low temperature fluidity, low evaporativity, and thermal stability and oxidation stability IDEMITSU KOSAN CO., LTD. (JP) 2013-02-12 US disclosed
EP-0945471-B1 CATALYSTS FOR THE POLYMERIZATION OF OLEFINS, PROCESS FOR THE PRODUCTION OF OLEFIN POLYMERS, AND PROCESSES FOR THE PRODUCTION OF STYRENE POLYMERS IDEMITSU KOSAN CO (JP) 2009-05-13 EP disclosed
US-20080146469-A1 Process for producing saturated aliphatic hydrocarbon compound, and lubricant composition IDEMITSU KOSAN CO., LTD. (JP) 2008-06-19 US disclosed
EP-1880986-A1 PROCESS FOR PRODUCING SATURATED ALIPHATIC HYDROCARBON COMPOUND, AND LUBRICANT COMPOSITION IDEMITSU KOSAN CO., LTD. (JP) 2008-01-23 EP disclosed
US-6787499-B2 Catalyst for the production of α-olefin and α-olefin production method IDEMITSU PETROCHEMICAL CO., LTD. (JP) 2004-09-07 US disclosed
US-20040097366-A1 Polyolefin-based composite resin, method for production thereof, catalyst for polymerization of vinly compound and method for polymerization of vinly compound using the same IDEMITSU KOSAN CO. LTD. (JP) 2004-05-20 US disclosed
US-20030134991-A1 Catalyst for the production of alpha-olefin and alpha-olefin production method thereof IDEMITSU PETROCHEMICAL CO., LTD. (JP) 2003-07-17 US disclosed
EP-0601830-A2 Catalyst components for polymerization of olefins and use thereof MITSUBISHI CHEMICAL CORPORATION (JP) 1994-06-15 EP disclosed
EP-0598543-A2 Method for producing Alpha-olefin polymers MITSUBISHI CHEMICAL CORPORATION (JP) 1994-05-25 EP disclosed
EP-0589638-A2 Powder catalyst composition and process for polymerizing olefins with the use thereof MITSUBISHI CHEMICAL CORPORATION (JP) 1994-03-30 EP disclosed
EP-0574258-A2 Process for producing alpha-olefin polymers MITSUBISHI CHEMICAL CORPORATION (JP) 1993-12-15 EP disclosed
EP-0566349-A2 Process for producing alpha-olefin polymers MITSUBISHI CHEMICAL CORPORATION (JP) 1993-10-20 EP disclosed
US-5252677-A Epoxy, hydroxy or sulfonic acid end groups MITSUBISHI PETROCHEMICAL COMPANY LIMITED (JP) 1993-10-12 US disclosed
EP-0538749-A1 Propylene copolymer composition MITSUBISHI PETROCHEMICAL CO., LTD. (JP) 1993-04-28 EP disclosed
EP-0511846-A1 Aminated olefin polymers MITSUBISHI CHEMICAL CORPORATION (JP) 1992-11-04 EP disclosed
EP-0498675-A2 Production of alpha-olefin polymers MITSUBISHI CHEMICAL CORPORATION (JP) 1992-08-12 EP disclosed
EP-0487278-A2 Functionalized olefin polymers MITSUBISHI CHEMICAL CORPORATION (JP) 1992-05-27 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080146469-A1 Process for producing saturated aliphatic hydrocarbon compound, and lubricant composition ALOX15, ALOX12, ALOX15B HTR2A 411/4885HTR6 435/4885SIGMAR1 489/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.